|
|
|
|
|
|
| Experienced leader to guide Company's expanding consulting capabilities to support improved decision making for biopharmaceutical customers worldwide |
Camberley, UK, Feb 25, 2014 - (ACN Newswire) - INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the appointment of Jane Winter as Senior Vice President, Global Consulting. Based in the United Kingdom, Ms. Winter will leverage her extensive clinical research background within the pharmaceutical and CRO industries to lead the Company's global consulting unit. This business unit is responsible for providing biopharmaceutical customers with world-class consulting in the areas of drug development and commercialization, regulatory consulting and submissions, and quality assurance (QA).
"Making informed decisions regarding product or portfolio development is just one of many challenges that pharmaceutical executives must address to remain competitive and maximize their return on investment," said Alistair Macdonald, Chief Operating Officer. "To expand the breadth of support to our customers, INC Research has continued to strengthen our consulting practice with a number of senior appointments, including Jane's. Her leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimization and compliance. These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers' most pressing business needs in drug development today."
Ms. Winter has more than 30 years' experience in the pharmaceutical industry. Prior to joining INC Research, she served as interim Global Head of Outsourcing at a major Japanese biopharmaceutical company, where she was responsible for leading the rollout of its global vendor governance and oversight model. Having worked for both pharma and international CROs, Ms. Winter has broad industry expertise and has held senior management positions in a range of functions, including project and operations management, clinical development, strategic business planning and international clinical affairs. Her background also includes establishing her own consulting company, Pharma Business Solutions Ltd, to assist biopharmaceutical companies and CROs maximize the effectiveness of clinical development and outsourcing. Ms. Winter serves on the board of directors for the Pan-Asian Clinical Research Association (PACRA), a non-profit organization in Singapore dedicated to the professional development of clinical research personnel based in Asia Pacific, and is a fellow of the Institute of Clinical Research.
Strategic Consulting at INC Research
INC Research offers the full range of consulting services to support product development from Phase I to launch and beyond. Through an integrated services model, the Company provides unparalleled clinical expertise with extensive strategic advisory capabilities to help biopharmaceutical organizations mitigate risks, maximize resources, and offer greater insight into product development lifecycles, commercialization opportunities and challenges. Customers are able to fully leverage a broad regulatory and development strategy expertise to find optimal claims and global regulatory pathways for their products. For more information on INC Research Strategic Advisory Services, please visit the Strategic Advisory Services section of the INC Research website.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. Our Trusted Process(R) methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact:
Lori Dorer, Media
+1-513-345-1685
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: Executive appointment
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
